The effect of Royal jelly on liver enzymes and glycemic indices: A systematic review and meta-analysis of randomized clinical trials

• Main Authors: Hossein Bahari (Author), Shaghayegh Taheri (Author), Mohammad Rashidmayvan (Author), Sanaz Jamshidi (Author), Mostafa Shahraki Jazinaki (Author), Naseh Pahlavani (Author)
• Format: Book
• Published: Elsevier, 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

Background: Royal jelly (RJ) may contribute to glycemic control and liver function through various mechanisms. The present study aimed to quantify the effect of RJ supplementation on these outcomes. Methods: A literature search of Web of Science, Scopus, and PubMed/Medline, was conducted for RCTs investigating the efficacy of RJ on plasma liver enzymes and glycemic indices. Weighted mean differences (WMDs) and 95% confidence intervals (CIs) were calculated for net changes using a random-effects model. Results: Ten RCTs were selected for inclusion in this meta-analysis. Combined estimate of effect sizes for the impact of RJ on neither the plasma liver enzymes nor the glycemic indices were statistically significant. Subgroup analysis showed a significant reduction of serum FPG in trials with intervention duration ≥ 8 weeks (WMD: −4.28 mg/dl, 95% CI −7.41 to −1.14 mg/dl, p = 0.007), and those conducted in non-healthy populations (WMD: −4.28 mg/dl, 95% CI −7.41 to −1.14, p = 0.007). Conclusion: RJ does not significantly affect liver function and glycemic profile of adult population. In trials with longer intervention and those conducted in non-healthy populations a significant reduction of serum FBG was observed. This meta-analysis should be repeated in the future, with more primary articles included, in order to provide conclusive results.

Item Description

0965-2299
10.1016/j.ctim.2023.102974